In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Latest Inception Sciences experiment to tackle MS; Roche has option to buy Inception 5; exercised

Executive Summary

Roche signed an exclusive funding and option-to-acquire deal with Inception Sciences Inc. (incubator involved in drug discovery) and its new spin-off Inception 5 Inc., focused on multiple sclerosis.
Deal Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes M&A Option
    • R+D and Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register